Beryl Drugs

Beryl Drugs Enterprise Value

The Enterprise Value (EV) of Beryl Drugs (524606.BO) as of Nov 3, 2026 is 111.77 M INR. In the previous year, Enterprise Value (EV) was 129.13 M INR — a change of -13.44% (lower).

Enterprise Value

111.77 MINR

YoY

-13.44%

Last updated:

Enterprise Value (EV) of Beryl Drugs is 2026 111.77 M INR. Enterprise Value (EV) of Beryl Drugs was 2025 129.13 M INR. It decreases by -13.44% lower compared to the previous year.

The Beryl Drugs Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
124.74 M INR
Jan 1, 2020
152.91 M INR
Jan 1, 2021
148.59 M INR
Jan 1, 2022
150.06 M INR
Jan 1, 2023
138.83 M INR
Jan 1, 2024
135.81 M INR
Jan 1, 2025
129.13 M INR
Jan 1, 2026
111.77 M INR
The Beryl Drugs Enterprise Value history
YEAREnterprise ValueYoY
111.77 MINR-13.44%
129.13 MINR-4.92%
135.81 MINR-2.18%
138.83 MINR-7.49%
150.06 MINR+0.99%
148.59 MINR-2.82%
152.91 MINR+22.58%
124.74 MINR+10.88%
112.50 MINR-13.36%
129.85 MINR+0.83%
128.79 MINR-0.33%
129.21 MINR+1.63%
127.13 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Beryl Drugs Stock analysis

What does Beryl Drugs do? Beryl Drugs Ltd. manufactures bulk drugs and offers small volume injectables in liquid and dry powder forms, eye and ear drops, intravenous fluids in poly packs and glass bottles, and veterinary medicines. The company supplies domestically, institutionally, and for export, leveraging its Pithampur manufacturing facility. It markets branded and generic pharmaceutical formulations through its nationwide sales and distribution network. The firm's revenue streams come from the sale of bulk drugs to pharmaceutical manufacturers and the distribution of branded and generic formulations to domestic and international markets. Institutional buyers include hospitals and healthcare providers, while export markets receive bulk drug supplies and veterinary medicines. Domestic sales focus on retail pharmacies and healthcare institutions. Beryl Drugs Ltd. serves the pharmaceutical industry by providing bulk drug manufacturing services and branded generic formulations. Its products are distributed through a nationwide network, targeting both institutional and retail segments. The company's export segment includes veterinary medicines and bulk drug supplies to international clients. Beryl Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beryl Drugs stock

Enterprise Value (EV) of Beryl Drugs is 111.77 M INR in 2026.

Enterprise Value (EV) of Beryl Drugs changed from 129.13 M INR to 111.77 M INR, representing a -13.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Beryl Drugs since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Beryl Drugs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Beryl Drugs

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Beryl Drugs